Systemic 5-fluorouracil producing an inflammatory response in porokeratosis

W. K. Nahm; K. G. Donohue; J. F. Danahy; E. Badiavas; V. Falanga

doi:10.1046/j.1468-3083.2003.00575.x

Systemic 5-fluorouracil producing an inflammatory response in porokeratosis

W. K. Nahm, K. G. Donohue, J. F. Danahy, E. Badiavas, V. Falanga

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.

Original language	English (US)
Pages (from-to)	190-192
Number of pages	3
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	17
Issue number	2
DOIs	https://doi.org/10.1046/j.1468-3083.2003.00575.x
State	Published - Mar 2003
Externally published	Yes

Keywords

5-fluorouracil
Actinic keratosis
Chemotherapy
Porokeratosis

ASJC Scopus subject areas

Dermatology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1046/j.1468-3083.2003.00575.x

Cite this

@article{cd7335bda9a6461baa6dfff83db1d076,

title = "Systemic 5-fluorouracil producing an inflammatory response in porokeratosis",

abstract = "Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.",

keywords = "5-fluorouracil, Actinic keratosis, Chemotherapy, Porokeratosis",

author = "Nahm, {W. K.} and Donohue, {K. G.} and Danahy, {J. F.} and E. Badiavas and V. Falanga",

year = "2003",

month = mar,

doi = "10.1046/j.1468-3083.2003.00575.x",

language = "English (US)",

volume = "17",

pages = "190--192",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Systemic 5-fluorouracil producing an inflammatory response in porokeratosis

AU - Nahm, W. K.

AU - Donohue, K. G.

AU - Danahy, J. F.

AU - Badiavas, E.

AU - Falanga, V.

PY - 2003/3

Y1 - 2003/3

N2 - Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.

AB - Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.

KW - 5-fluorouracil

KW - Actinic keratosis

KW - Chemotherapy

KW - Porokeratosis

UR - http://www.scopus.com/inward/record.url?scp=0037357682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037357682&partnerID=8YFLogxK

U2 - 10.1046/j.1468-3083.2003.00575.x

DO - 10.1046/j.1468-3083.2003.00575.x

M3 - Article

C2 - 12705749

AN - SCOPUS:0037357682

VL - 17

SP - 190

EP - 192

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 2

ER -

Systemic 5-fluorouracil producing an inflammatory response in porokeratosis

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this